Original Research
Published on 10 Jul 2024
Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023
in Drugs Outcomes Research and Policies
- 967 views
Original Research
Published on 10 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 10 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 08 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 05 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 02 Jul 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 28 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 27 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 26 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 24 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 24 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 20 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 18 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 17 Jun 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 14 Jun 2024
in Drugs Outcomes Research and Policies